Gyros Showcases Nanoliter-scale Immunoassay System Gyrolab xPlore™ at SOT 54th Annual Meeting & ToxExpo™
(Uppsala, Sweden; March 17, 2015) — Gyros AB, a pioneer in miniaturizing and automating immunoassays at nanoliter-scale, is showcasing its new Gyrolab xPlore at the SOT 54th Annual Meeting & ToxExpo™ in San Diego, March 22 to 26.
Gyros’ new system Gyrolab xPlore is a smaller version of the widely used five-CD Gyrolab™ xP workstation. Gyrolab xPlore is a more compact, cost-effective, single-CD system that makes automated nanoliter-scale immunoassays accessible to laboratories of every size. Gyros’ open platforms simplify assay workflows by eliminating incubations and shortening run times. Gyros technology delivers high-quality data with broad dynamic ranges and excellent reproducibility while dramatically reducing sample consumption.
Analytically validated biomarker kits are available from EMD Millipore. Gyrolab xPlore users can chose from a selection of currently available assays or work with the EMD Millipore custom assay team for specific needs (firstname.lastname@example.org). Recently released assays include GyroMark™ HT Rat/ Mouse Cystatin C, Rat Lipocalin-2/NGAL, and Rat β2-Microglobulin assays.
“With Gyros’ technology, assays can be developed quickly in a variety of matrices and customers have full flexibility in choosing an assay format.” said Dan Calvo, president and CEO of Gyros. “EMD Millipore’s validated biomarker kits give our users easy access to high quality, sensitive assays that require very small sample volumes”.
Gyros is showcasing Gyrolab xPlore and GyroMark HT Kits in Booth 1044 at ToxExpo™ and is presenting “Automated Microsampling at Nanoliter-Scale: Improving Your 3R Strategies for Bioanalysis” in Room 22 at 4:45-5:45 p.m. Monday, March 23. To see Gyrolab xPlore in action, visit www.gyros.com.
Gyros manufactures laboratory instruments, consumables, kits and software to maximize laboratory productivity by miniaturizing and automating immunoassays at nanoliter-scale. Gyrolab™ systems use proven microfluidic CD technology to analyze large numbers of samples in parallel, ensuring uniform processing and yielding up to 112 data points in less than one hour. Gyros will put a new spin on what’s possible in your laboratory. Learn more at Gyros.com.
High resolution images:
Phone: +1 308.237.5567
For Gyros AB
Katie Odgaard / Lorna Cuddon
Zyme Communications Ltd
Tel: +44 (0) 7787 502 947 / +44 (0) 7811 996 942
Skype: kodgaard / lorna.cuddon
Email: email@example.com / firstname.lastname@example.org
Notes to editors:
About Gyros (www.gyros.com)
Gyros AB is the world leader in utilization of microfluidic technologies to miniaturize and automate immunoassays. The Gyros™ immunoassay platform increases productivity and efficiency during development of biotherapeutics and vaccines, saving time and labor. Major biopharmaceutical companies and their service providers utilize the Gyros platform to boost time-critical workflows and meet increasing regulatory demands.
Spanning the entire spectrum of immunoassays, the platform cuts the time to result significantly. Faster development times, and unattended running of assays at nano-liter scale, save labor and sample. The ease of assay transfer between sites and from development to regulated environments is unsurpassed in the industry.
The company is based in Uppsala, Sweden and has regional sales and support offices in the USA and Europe, and a growing network of distributors.